ALR Technologies SG Ltd. income statement ALRTF

Annual Quarterly

It recorded a net loss of $22.1 million. Diluted earnings per share were -$0.04.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022
Revenue	—	—	0 +978.8%	0
Cost of revenue	—	—	0 +1778.9%	0
Gross profit	—	—	0 +188.8%	0
Research and development	1 -10.2%	1 -37.1%	1 +191.3%	0
Selling, general and administrative	1 -27.0%	2 -22.4%	3 -9.4%	3
Operating income	—	—	—	4
Pretax income	-2	—	—	—
Net income	-22 -38.9%	-16 -112.4%	-7 +29.6%	-11
Basic EPS	—	-0.03	—	—
Diluted EPS	-0.04 -33.3%	-0.03	—	—
Weighted average shares, basic	—	599	—	—
Weighted average shares, diluted	607 +1.3%	599	—	—
Margins
Gross margin	—	—	13.47%	50.32%
Operating margin	—	—	—	180,380.19%
Profit margin	—	—	-29,270.50%	-448,618.88%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ALRTF (OTC)
Headquarters: Singapore, Singapore
SEC filer status: Non-accelerated filer
SEC CIK: 1930419
Former names: ALR Technologies SG Pte. Ltd. (until Sep 23, 2022)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.